Latest News


Filter by tags: Netherlands Clear all tag filters

148 news articles found

The Nuclear Alliance, a French initiative comprising 16 European countries seeking to further develop nuclear power, has issued a statement calling on the European Commission (EC) to recognise nuclear energy in the EU's energy strategy and relevant policies. The statement came after a meeting in Paris with European Commissioner for Energy Kadri Simson.

Date: Friday, 19 May 2023
Original article:

Nuclear could provide up to 150 GWe of generating capacity by 2050 in the European Union, according to a statement issued by 16 European countries following a meeting in Paris with European Commissioner for Energy Kadri Simson. The so-called Nuclear Alliance called on the European Commission to recognise nuclear energy in the EU's energy strategy and relevant policies.

Date: Thursday, 18 May 2023
Original article:

Work has begun to build the foundations for the Pallas research reactor in Petten, the Netherlands, which will replace the existing High Flux Reactor (HFR). However, the Dutch government has yet to make a final decision on constructing the reactor.

Date: Saturday, 06 May 2023
Original article:

In its draft Climate Fund for 2024, the Dutch government has budgeted funds totalling EUR320 million (USD352 million) for the development of nuclear energy. The funds will be used for the preparation of the operational extension of the existing Borssele nuclear power plant, the construction of two new large reactors, the development of small modular reactors (SMRs) and for nuclear skills development in the Netherlands.

Date: Friday, 28 April 2023
Original article:

Recent geopolitical events have focused world attention on the importance of energy security and the vital role that nuclear can play in providing clean, reliable energy. This is causing momentum to build in both nuclear generation plans and the supply chain to support it, said the keynote panellists at the World Nuclear Fuel Cycle 2023 (WNFC 2023) conference in the Netherlands.

Date: Thursday, 20 April 2023
Original article:

Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Date: Friday, 14 April 2023
Original article:

Final funding decision still pending from Dutch government The new the Pallas plant will replace the ageing high-flux reactor (HFR) at Petten. Courtesy Pallas. Plans to build a new research reactor in the Netherlands have taken a significant step forward with a licence for construction officially entering into force.

On 15 February 2023, the nuclear regulator, the Authority for Nuclear Safety and Radiation Protection (ANVS), granted a licence under the Nuclear Energy Act for construction of the Pallas reactor, which will replace the ageing high-flux reactor (HFR) at Petten in the province of Noord-Holland. Pallas had submitted the application in June 2022.

The issue of the licence was followed by an objection period for appeals to be filed. That objection period has now come to an end and the licence is effective, Pallas said in a statement on Wednesday (12 April).

Date: Thursday, 13 April 2023
Original article:

Urenco says it is withdrawing its support for the U-Battery advanced modular reactor (AMR) project "having exhausted its attempts to secure the commitment of new commercial investors". The U-Battery project was initiated by Urenco in 2008 based on a concept design developed by the Universities of Manchester and Dalton Institute in the UK and Technology University of Delft in the Netherlands. The design is for a 4 MWe high-temperature gas-cooled micro-reactor using high-integrity TRISO fuel. It is intended to produce local power and heat to replace diesel power for a variety of applications, including remote communities and other off-grid locations such as mining operations.

Date: Thursday, 23 March 2023
Original article:

Belgium’s Tractebel (part of French energy company Engie) and Dutch research and production organisation NRG PALLAS have signed a Memorandum of Understanding (MOU) to cooperate in support nuclear newbuild in the Netherlands. The MOU was signed at the Embassy of Belgium in The Hague on the sidelines of the Belgium - Netherlands Nuclear Summit.

Date: Wednesday, 22 March 2023
Original article: